R. Solá

Thymosin alpha‐1 with peginterferon alfa‐2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?

A. Mangia, S. Pol, M. Milella, 2012, Journal of viral hepatitis.

Comparative study of the efficacy of an induction dose of interferon‐α2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C

M. Diago, J. Crespo, L. Rodrigo, 2003, Journal of viral hepatitis.

Safety and efficacy of an induction dose of pegylated interferon alpha‐2a on early hepatitis C virus kinetics in HIV/HCV co‐infected patients: the CORAL‐1 multicentre pilot study

B. Clotet, C. Tural, C. Quereda, 2007, Journal of viral hepatitis.

[Induction therapy with interferon alfa-2a in compensated hepatitis C virus-related cirrhosis. Randomized, multicenter study].

C. Richart, B. Dalmau, J. Boadas, 2002, Medicina clínica (Ed. impresa).

Chronic inflammation in hepatitis C patients is associated with increased perceived stress and abnormal connectivity between insula and basal ganglia

J. Leza, X. Forns, R. Navinés, 2018, European Neuropsychopharmacology.

Thymosin alpha‐1 with peginterferon alfa‐2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?

A. Mangia, S. Pol, M. Milella, 2012, Journal of viral hepatitis.

P.2.b.054 Psychiatric induced disorders and quality of life of substance abusers with chronic hepatitis C under interferon-alpha treatment

M. Torrens, R. Navinés, M. Udina, 2013, European Neuropsychopharmacology.